Uncategorized
Inotek reports $10.7 million first-quarter net loss
Inotek Pharmaceuticals reported a $10.7 million net loss in the first quarter of 2017 compared with a $10.1 million net loss in 2016’s first quarter, according to a press release.Research and development costs decreased from $7.6 million in the first quarter of 2016 to $7.1 million, whereas general and administrative costs increased from $2.5 million to $2.9 million.